Cited by 88Wound Healing and TreatmentsDiabetic Foot Ulcer Assessment and ManagementBurn Injury Management and Outcomes

Effect of Recombinant Platelet-Derived Growth Factor (Regranex®) on Wound Closure in Genetically Diabetic Mice

Chan, Rodney K., Liu, Perry H., Pietramaggiori, Giorgio, Ibrahim, Shahrul I., Hechtman, Herbert B., Orgill, Dennis P.·2006·Journal of Burn Care & Research

Abstract

Burns, especially those involving large surface areas, represent a complex wound healing problem. Platelet-derived growth factor (PDGF) is released by activated platelets to recruit inflammatory cells toward the wound bed. It has effects on promoting angiogenesis and granulation tissue formation. However, the effectiveness of topical PDGF on wound closure is variable, ranging from little improvement observed in pig models to dramatic improvement reported in a diabetic mouse model. Here, we sought to determine the effectiveness of commercially sold PDGF-BB (Regranex) on wound closure in genetically diabetic mice. C57BL/KsJ db+/db+ mice and its host strain bearing dorsal 1.5-cm wounds were divided into groups (n = 8 in each group) receiving topical application of either Regranex (10 microg/wound) or vehicle for 5 consecutive days after wounding. The rate of wound closure was analyzed using computerized planimetry. The amount of granulation tissue was determined histologically. Our data indicate that diabetic mice exhibit a significant delay in wound closure when compared with their host strain. Topical application of Regranex did not improve the time to wound closure but did significantly increase the amount of granulation tissue. Our current study using commercially available Regranex failed to reproduce the previously reported finding that PDGF improved wound closure in healing impaired genetically diabetic mice.

Integrity signals

Registry

Crossref · 10.1097/01.bcr.0000202898.11277.58

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Despite limitations, mouse models have been instrumental in preclinical testing, leading to clinical trials and approval of products such as Regranex (PDGF-BB).

    “Despite the limitations of mouse models, they have been instrumental in pre-clinical testing, leading to clinical trials and approval of products such as Regranex (PDGF-BB) (62, 115, 116).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chan, R. K., Liu, P. H., Pietramaggiori, G., Ibrahim, S. I., Hechtman, H. B., & Orgill, D. P.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Orgill, Dennis P.
Venue
Journal of Burn Care & Research
Published
2006-03
Volume
27
Issue
2
Pages
202-205
ISSN
1559-047X (ISSN-L)
OpenAlex
W2049524851
Cited by
88
References
12
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 3 · 2018: 8 · 2017: 2 · 2016: 6 · 2015: 5 · 2014: 10 · 2013: 4 · 2012: 2
FWCI
5.63
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Burn Care & Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
  • Health Sciences › Medicine › Epidemiology › Burn Injury Management and Outcomes
Keywords
platelet-derived growth factor, PDGF-BB, wound closure, diabetic wound healing, diabetic mice, granulation tissue, burns, topical growth factor therapy
MeSH terms
Becaplermin, Administration, Topical, Animals, Diabetes Mellitus, Experimental, Male, Mice, Inbred C57BL, Platelet-Derived Growth Factor, Time Factors, Wound Healing, Wounds, Nonpenetrating, Proto-Oncogene Proteins c-sis, Angiogenesis Inducing Agents, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review